Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
-1.22%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$39.8B
AUM Growth
-$3.97B
(-9.1%)
Cap. Flow
-$3.14B
Cap. Flow
% of AUM
-7.88%
Top 10 Holdings %
Top 10 Hldgs %
10.96%
Holding
3,846
New
599
Increased
854
Reduced
696
Closed
741
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$321M |
| 2 |
Kroger
KR
|
+$256M |
| 3 |
Pinterest
PINS
|
+$207M |
| 4 |
AT&T
T
|
+$198M |
| 5 |
Chevron
CVX
|
+$190M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$443M |
| 2 |
Merck
MRK
|
+$443M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$289M |
| 4 |
Coca-Cola
KO
|
+$266M |
| 5 |
Eli Lilly
LLY
|
+$237M |
Sector Composition
| 1 | Financials | 21.85% |
| 2 | Technology | 18.52% |
| 3 | Healthcare | 17.68% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Consumer Staples | 6.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Royal Bank of Canada
RY
$203B
| $1.15M | ﹤0.01% |
12,800
-34,200
| -73% | -$3.08M |
|
1727
A10 Networks
ATEN
$1.26B
| $1.15M | ﹤0.01% |
+86,589
| New | +$1.15M |
|
1728
BARK
BARK
$150M
| $1.15M | ﹤0.01% |
631,371
-220,293
| -26% | -$401K |
|
|
EVRI
1729
DELISTED
Everi Holdings
EVRI
| $1.14M | ﹤0.01% |
70,266
-272,324
| -79% | -$4.41M |
|
1730
Immunocore
IMCR
$1.78B
| $1.13M | ﹤0.01% |
24,120
| – | – |
|
1731
LGI Homes
LGIH
$1.39B
| $1.13M | ﹤0.01% |
+13,909
| New | +$1.13M |
|
|
IMGN
1732
DELISTED
Immunogen Inc
IMGN
| $1.13M | ﹤0.01% |
+236,200
| New | +$1.13M |
|
1733
Torrid Holdings
CURV
$189M
| $1.13M | ﹤0.01% |
269,717
-59,674
| -18% | -$249K |
|
1734
Acushnet Holdings
GOLF
$4.38B
| $1.12M | ﹤0.01% |
+25,825
| New | +$1.12M |
|
1735
Voyager Therapeutics
VYGR
$232M
| $1.12M | ﹤0.01% |
+189,736
| New | +$1.12M |
|
1736
Ingredion
INGR
$8.09B
| $1.12M | ﹤0.01% |
13,936
+4,365
| +46% | +$351K |
|
1737
Carvana
CVNA
$50B
| $1.12M | ﹤0.01% |
55,199
-2,483,718
| -98% | -$50.4M |
|
1738
MDU Resources
MDU
$3.32B
| $1.12M | ﹤0.01% |
+107,528
| New | +$1.12M |
|
1739
TriplePoint Venture Growth BDC
TPVG
$267M
| $1.12M | ﹤0.01% |
102,979
+71,022
| +222% | +$771K |
|
|
RVNC
1740
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.12M | ﹤0.01% |
41,253
+24,395
| +145% | +$659K |
|
|
THRD
1741
DELISTED
Third Harmonic Bio
THRD
| $1.11M | ﹤0.01% |
+58,465
| New | +$1.11M |
|
|
SJI
1742
DELISTED
South Jersey Industries, Inc.
SJI
| $1.11M | ﹤0.01% |
+33,214
| New | +$1.11M |
|
1743
Exact Sciences
EXAS
$10.2B
| $1.1M | ﹤0.01% |
33,823
+27,621
| +445% | +$897K |
|
1744
Beyond Meat
BYND
$205M
| $1.1M | ﹤0.01% |
+77,258
| New | +$1.1M |
|
1745
Brinker International
EAT
$6.84B
| $1.09M | ﹤0.01% |
43,432
+28,150
| +184% | +$703K |
|
1746
Helen of Troy
HELE
$554M
| $1.08M | ﹤0.01% |
11,200
-11,303
| -50% | -$1.09M |
|
1747
Grupo Aeroportuario del Pacifico
PAC
$12.9B
| $1.08M | ﹤0.01% |
8,524
+51
| +0.6% | +$6.46K |
|
1748
Smith & Nephew
SNN
$16.4B
| $1.08M | ﹤0.01% |
46,286
-58,042
| -56% | -$1.35M |
|
1749
DIH Holdings US
DHAI
$10.7M
| $1.07M | ﹤0.01% |
107,008
| – | – |
|
1750
Aldeyra Therapeutics
ALDX
$324M
| $1.07M | ﹤0.01% |
200,163
+122,482
| +158% | +$654K |
|